483 Tedor Pharma Jan 2006

483 Tedor Pharma Jan 2006

Richard Penta FDA$119.00 - Available Now

FDA investigators audited the Tedor Pharma - Cumberland, RI, United States facility and issued inspectional observations (via FDA 483) on 20 Jan 2006.

Product details

  • Category: Human Drugs
  • Inspection end: 20 Jan 2006
  • Location: Cumberland, United States
  • FEI: 3003855180
Add To Cart